Inside Drug Pricing - 03/23/2020

Stimulus Bill Jeopardizes Drug Pricing, Surprise Billing Policies

By Ariel Cohen / March 22, 2020 at 4:29 PM
The Senate GOP’s third coronavirus stimulus bill includes several Medicare and Medicaid extenders, which jeopardizes the surprise billing and drug pricing policies that were excluded. Senate Finance Committee Chair Chuck Grassley (R-IA) on Saturday warned against including extenders without drug pricing in the third stimulus bill, which was introduced Sunday. GOP leaders hope to move the bill through the Senate Monday, but were still negotiating with Democrats on Sunday. “Pres @realDonaldTrump promised to lower Rx prices & he’s been a...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.